NASDAQ:VOR

Vor Biopharma Stock Predictions

etoro logo Buy VOR
*Your capital is at risk
$13.44
-0.220 (-1.61%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

VOR Prediction Chart

VOR Predictions History

Latest community submissions for VOR.
Predictor Target Session Target Price Result Direction Accuracy Score
Sep 15, 2025 $1.81 +4.09% $1.60 X 86.80% 0
Sep 15, 2025 $1.78 +2.56% $1.60 X 88.47% 0
Sep 15, 2025 $3.00 +72.41% $1.60 X 12.50% 0
Jul 29, 2025 $2.34 -3.49% $2.35 V 99.39% 4
Jul 29, 2025 Bullish $2.35 V 0
Jul 25, 2025 $2.03 -6.43% $2.20 X 92.30% 0
Jul 25, 2025 $2.26 +4.02% $2.20 V 97.40% 1
Jul 25, 2025 Bullish $2.20 V 1
Jul 22, 2025 $2.21 +7.70% $2.05 X 92.30% 0
Jul 22, 2025 $2.15 +4.81% $2.05 X 95.19% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VOR with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT VOR BIOPHARMA INC.
Vor Biopharma
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML blood cancer cells. The company's eHSCs targeted therapies, such as CAR-Ts, bispecific antibodies, an...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE